The invention relates to heterocyclic compounds consisting of a core nitrogen atom surrounded by three pendant groups, wherein two of the three pendant groups are preferably benzimidazolyl methyl and tetrahydroquinolyl, and the third pendant group contains N and optionally contains additional rings. The compounds bind to chemokine receptors, including CXCR4 and CCR5, and demonstrate protective effects against infection of target cells by a human immunodeficiency virus (HIV).

 
Web www.patentalert.com

< Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives

> Chemokine receptor binding heterocyclic compounds with enhanced efficacy

~ 00424